Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fangfang Liu

Showing results (511-520 of 535) with videos related to

Pageof 54
Sort By:
Nature Cell Biology|January 7, 2026
SLC2A1<sup>+</sup> tumour-associated macrophages spatially control CD8<sup>+</sup> T cell function and drive resistance to immunotherapy in non-small-cell lung cancerLei Wang, Han Chu, Degao Chen, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|January 15, 2021
Oral microbiome and risk of malignant esophageal lesions in a high-risk area of China: A nested case-control studyFangfang Liu, Mengfei Liu, Ying Liu, et al.
Journal of the American Chemical Society|April 30, 2025
Groove-Confined Cobalt Catalyst for Low-Temperature CO<sub>2</sub> ActivationXiaowei Chang, Chengying Yu, Chen Yang, et al.
International Journal of Surgery (London, England)|November 20, 2023
Surgical quality determines the long-term survival superiority of right over left thoracic esophagectomy for localized esophageal squamous cell carcinoma patients: a real-world multicenter studyFangfang Liu, Wenlei Yang, Yu He, et al.
Annals of Surgery|June 6, 2021
Is Adjuvant Therapy a Better Option for Esophageal Squamous Cell Carcinoma Patients Treated With Esophagectomy? A Prognosis Prediction Model Based on Multicenter Real-World DataWenlei Yang, Fangfang Liu, Ruiping Xu, et al.
Annals of Surgery|February 7, 2022
Minimally Invasive or Open Esophagectomy for Treatment of Resectable Esophageal Squamous Cell Carcinoma? Answer From a Real-world Multicenter StudyFangfang Liu, Wenlei Yang, Wei Yang, et al.
Eclinicalmedicine|April 28, 2022
Update and validation of a diagnostic model to identify prevalent malignant lesions in esophagus in general populationMengfei Liu, Ren Zhou, Zhen Liu, et al.
Eclinicalmedicine|March 28, 2020
Estimating cancer incidence based on claims data from medical insurance systems in two areas lacking cancer registries in ChinaHongrui Tian, Wei Yang, Yanjun Hu, et al.
Beijing Da Xue Xue Bao. Yi Xue Ban = Journal of Peking University. Health Sciences|June 13, 2026
[Perioperative hyperglycemia predicts poorer prognosis of esophageal squamous cell carcinoma patients treated with esophagectomy]Bo Peng, Fangfang Liu, Wei Yang, et al.
The Journal of Pathology|May 25, 2023
Multiscale deep learning framework captures systemic immune features in lymph nodes predictive of triple negative breast cancer outcome in large-scale studiesGregory Verghese, Mengyuan Li, Fangfang Liu, et al.
Pageof 54

Showing results (511-520 of 535) with videos related to

Sort By:
Pageof 54
Nature Cell Biology|January 7, 2026
SLC2A1<sup>+</sup> tumour-associated macrophages spatially control CD8<sup>+</sup> T cell function and drive resistance to immunotherapy in non-small-cell lung cancerLei Wang, Han Chu, Degao Chen, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|January 15, 2021
Oral microbiome and risk of malignant esophageal lesions in a high-risk area of China: A nested case-control studyFangfang Liu, Mengfei Liu, Ying Liu, et al.
Journal of the American Chemical Society|April 30, 2025
Groove-Confined Cobalt Catalyst for Low-Temperature CO<sub>2</sub> ActivationXiaowei Chang, Chengying Yu, Chen Yang, et al.
International Journal of Surgery (London, England)|November 20, 2023
Surgical quality determines the long-term survival superiority of right over left thoracic esophagectomy for localized esophageal squamous cell carcinoma patients: a real-world multicenter studyFangfang Liu, Wenlei Yang, Yu He, et al.
Annals of Surgery|June 6, 2021
Is Adjuvant Therapy a Better Option for Esophageal Squamous Cell Carcinoma Patients Treated With Esophagectomy? A Prognosis Prediction Model Based on Multicenter Real-World DataWenlei Yang, Fangfang Liu, Ruiping Xu, et al.
Annals of Surgery|February 7, 2022
Minimally Invasive or Open Esophagectomy for Treatment of Resectable Esophageal Squamous Cell Carcinoma? Answer From a Real-world Multicenter StudyFangfang Liu, Wenlei Yang, Wei Yang, et al.
Eclinicalmedicine|April 28, 2022
Update and validation of a diagnostic model to identify prevalent malignant lesions in esophagus in general populationMengfei Liu, Ren Zhou, Zhen Liu, et al.
Eclinicalmedicine|March 28, 2020
Estimating cancer incidence based on claims data from medical insurance systems in two areas lacking cancer registries in ChinaHongrui Tian, Wei Yang, Yanjun Hu, et al.
Beijing Da Xue Xue Bao. Yi Xue Ban = Journal of Peking University. Health Sciences|June 13, 2026
[Perioperative hyperglycemia predicts poorer prognosis of esophageal squamous cell carcinoma patients treated with esophagectomy]Bo Peng, Fangfang Liu, Wei Yang, et al.
The Journal of Pathology|May 25, 2023
Multiscale deep learning framework captures systemic immune features in lymph nodes predictive of triple negative breast cancer outcome in large-scale studiesGregory Verghese, Mengyuan Li, Fangfang Liu, et al.
Pageof 54